Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19

In view of the rapid spread of COVID-19 and the high mortality rate of severe cases, reliable risk stratifying indicators of prognosis are necessary to decrease morbidity and mortality. The aim of the present study was to evaluate the value of serum amyloid A (SAA) and carcinoembryonic antigen (CEA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelhakam, Dina A., Badr, Fatma Mohammed, Abd El Monem Teama, Mohammed, Bahig Elmihi, Nouran M., El-Mohamdy, Marwa Adham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719318/
https://www.ncbi.nlm.nih.gov/pubmed/34987797
http://dx.doi.org/10.3892/br.2021.1496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719318/
https://www.ncbi.nlm.nih.gov/pubmed/34987797
http://dx.doi.org/10.3892/br.2021.1496

Ejemplares similares